Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents.

S M Leijen, J.H. Beijnen, J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)186-191
Number of pages6
JournalCurrent Clinical Pharmacology
Volume5
Issue number3
Publication statusPublished - 2010

Cite this